147 related articles for article (PubMed ID: 23739916)
1. HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.
Mohme M; Hotz C; Stevanovic S; Binder T; Lee JH; Okoniewski M; Eiermann T; Sospedra M; Rammensee HG; Martin R
Brain; 2013 Jun; 136(Pt 6):1783-98. PubMed ID: 23739916
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.
Wang J; Jelcic I; Mühlenbruch L; Haunerdinger V; Toussaint NC; Zhao Y; Cruciani C; Faigle W; Naghavian R; Foege M; Binder TMC; Eiermann T; Opitz L; Fuentes-Font L; Reynolds R; Kwok WW; Nguyen JT; Lee JH; Lutterotti A; Münz C; Rammensee HG; Hauri-Hohl M; Sospedra M; Stevanovic S; Martin R
Cell; 2020 Nov; 183(5):1264-1281.e20. PubMed ID: 33091337
[TBL] [Abstract][Full Text] [Related]
3. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
[TBL] [Abstract][Full Text] [Related]
4. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.
Prat E; Tomaru U; Sabater L; Park DM; Granger R; Kruse N; Ohayon JM; Bettinotti MP; Martin R
J Neuroimmunol; 2005 Oct; 167(1-2):108-19. PubMed ID: 16111772
[TBL] [Abstract][Full Text] [Related]
6. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
7. Tumor rejection effects of allorestricted tumor peptide-specific CD4(+) T cells on human cervical cancer cell xenograft in nude mice.
Song Y; Sun W; Weng X; Liang Z; Yu Q; Wang Z; Ouyang L; Chen J; Wu X; Shen G; Wu X
Cell Transplant; 2012; 21(7):1503-14. PubMed ID: 22525838
[TBL] [Abstract][Full Text] [Related]
8. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
[TBL] [Abstract][Full Text] [Related]
9. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis.
Rasmussen HB; Kelly MA; Clausen J
Mult Scler; 2001 Apr; 7(2):91-3. PubMed ID: 11424637
[TBL] [Abstract][Full Text] [Related]
10. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
[TBL] [Abstract][Full Text] [Related]
11. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.
Ooi JD; Petersen J; Tan YH; Huynh M; Willett ZJ; Ramarathinam SH; Eggenhuizen PJ; Loh KL; Watson KA; Gan PY; Alikhan MA; Dudek NL; Handel A; Hudson BG; Fugger L; Power DA; Holt SG; Coates PT; Gregersen JW; Purcell AW; Holdsworth SR; La Gruta NL; Reid HH; Rossjohn J; Kitching AR
Nature; 2017 May; 545(7653):243-247. PubMed ID: 28467828
[TBL] [Abstract][Full Text] [Related]
12. Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland.
Saastamoinen KP; Auvinen MK; Tienari PJ
Mult Scler; 2012 May; 18(5):563-8. PubMed ID: 22041092
[TBL] [Abstract][Full Text] [Related]
13. [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].
Nishimura Y
Nihon Rinsho; 1997 Jun; 55(6):1384-96. PubMed ID: 9200922
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
15. Memory B Cells Activate Brain-Homing, Autoreactive CD4
Jelcic I; Al Nimer F; Wang J; Lentsch V; Planas R; Jelcic I; Madjovski A; Ruhrmann S; Faigle W; Frauenknecht K; Pinilla C; Santos R; Hammer C; Ortiz Y; Opitz L; Grönlund H; Rogler G; Boyman O; Reynolds R; Lutterotti A; Khademi M; Olsson T; Piehl F; Sospedra M; Martin R
Cell; 2018 Sep; 175(1):85-100.e23. PubMed ID: 30173916
[TBL] [Abstract][Full Text] [Related]
16. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
Alizadeh M; Babron MC; Birebent B; Matsuda F; Quelvennec E; Liblau R; Cournu-Rebeix I; Momigliano-Richiardi P; Sequeiros J; Yaouanq J; Genin E; Vasilescu A; Bougerie H; Trojano M; Martins Silva B; Maciel P; Clerget-Darpoux F; Clanet M; Edan G; Fontaine B; Semana G
Ann Neurol; 2003 Jul; 54(1):119-22. PubMed ID: 12838528
[TBL] [Abstract][Full Text] [Related]
17. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model.
Ellmerich S; Mycko M; Takacs K; Waldner H; Wahid FN; Boyton RJ; King RH; Smith PA; Amor S; Herlihy AH; Hewitt RE; Jutton M; Price DA; Hafler DA; Kuchroo VK; Altmann DM
J Immunol; 2005 Feb; 174(4):1938-46. PubMed ID: 15699121
[TBL] [Abstract][Full Text] [Related]
18. Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?
da Silva Bernardes M; Antão Paiva CL; Ribeiro Paradela E; Papais Alvarenga M; Ferreira Pereira F; Vasconcelos CC; Papais Alvarenga RM
J Neuroimmunol; 2019 May; 330():74-80. PubMed ID: 30836273
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: doubling down on MHC.
Martin R; Sospedra M; Eiermann T; Olsson T
Trends Genet; 2021 Sep; 37(9):784-797. PubMed ID: 34006391
[TBL] [Abstract][Full Text] [Related]
20. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.
Sospedra M; Muraro PA; Stefanová I; Zhao Y; Chung K; Li Y; Giulianotti M; Simon R; Mariuzza R; Pinilla C; Martin R
J Immunol; 2006 Feb; 176(3):1951-61. PubMed ID: 16424227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
